Kimberly Lobo, M.P.H., M.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Saxitoxin | 1 | 2015 | 65 | 0.530 |
Why?
|
Anesthesia, Local | 1 | 2015 | 265 | 0.460 |
Why?
|
Bupivacaine | 1 | 2015 | 409 | 0.420 |
Why?
|
Epinephrine | 1 | 2015 | 795 | 0.410 |
Why?
|
Egg Hypersensitivity | 1 | 2021 | 44 | 0.190 |
Why?
|
Touch | 1 | 2022 | 306 | 0.190 |
Why?
|
Anesthetics, Local | 2 | 2017 | 987 | 0.170 |
Why?
|
Peanut Hypersensitivity | 1 | 2021 | 163 | 0.170 |
Why?
|
Muscular Atrophy, Spinal | 1 | 2022 | 258 | 0.160 |
Why?
|
Zygapophyseal Joint | 1 | 2020 | 126 | 0.160 |
Why?
|
Pain Measurement | 2 | 2017 | 3419 | 0.140 |
Why?
|
Complex Regional Pain Syndromes | 1 | 2017 | 124 | 0.130 |
Why?
|
Methyl Ethers | 1 | 2017 | 205 | 0.130 |
Why?
|
Hypesthesia | 1 | 2015 | 110 | 0.130 |
Why?
|
Propofol | 1 | 2021 | 626 | 0.120 |
Why?
|
Lipopolysaccharides | 1 | 2022 | 2208 | 0.120 |
Why?
|
Anesthesia, Conduction | 1 | 2017 | 240 | 0.120 |
Why?
|
Anesthesia, General | 2 | 2022 | 1164 | 0.120 |
Why?
|
Food Hypersensitivity | 1 | 2021 | 613 | 0.120 |
Why?
|
Harm Reduction | 1 | 2013 | 126 | 0.110 |
Why?
|
Anesthetics, Inhalation | 1 | 2017 | 571 | 0.100 |
Why?
|
Drug Users | 1 | 2013 | 132 | 0.100 |
Why?
|
Low Back Pain | 1 | 2020 | 948 | 0.100 |
Why?
|
Community-Based Participatory Research | 1 | 2013 | 213 | 0.100 |
Why?
|
Critical Illness | 1 | 2022 | 2656 | 0.090 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6478 | 0.060 |
Why?
|
Information Dissemination | 1 | 2013 | 1106 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10945 | 0.060 |
Why?
|
Pain Clinics | 1 | 2021 | 49 | 0.050 |
Why?
|
Electroencephalography | 1 | 2017 | 6133 | 0.050 |
Why?
|
Injections, Spinal | 1 | 2022 | 303 | 0.050 |
Why?
|
Double-Blind Method | 1 | 2015 | 11985 | 0.050 |
Why?
|
Thailand | 1 | 2021 | 296 | 0.050 |
Why?
|
Oligonucleotides | 1 | 2022 | 572 | 0.040 |
Why?
|
Substance-Related Disorders | 1 | 2013 | 4239 | 0.040 |
Why?
|
Prospective Studies | 4 | 2022 | 53037 | 0.030 |
Why?
|
Time | 1 | 2017 | 528 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1469 | 0.030 |
Why?
|
Child | 4 | 2022 | 77033 | 0.030 |
Why?
|
Neoplasms | 1 | 2021 | 21507 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2022 | 76631 | 0.030 |
Why?
|
Lumbar Vertebrae | 1 | 2020 | 1843 | 0.020 |
Why?
|
Humans | 9 | 2022 | 739398 | 0.020 |
Why?
|
Young Adult | 1 | 2015 | 56255 | 0.020 |
Why?
|
Male | 5 | 2021 | 349022 | 0.020 |
Why?
|
Infant | 2 | 2022 | 34923 | 0.020 |
Why?
|
Child, Preschool | 2 | 2022 | 40802 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 38942 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 13880 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2022 | 19811 | 0.020 |
Why?
|
Adult | 2 | 2015 | 213394 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2017 | 4426 | 0.010 |
Why?
|
Female | 4 | 2021 | 378853 | 0.010 |
Why?
|
Opioid-Related Disorders | 1 | 2013 | 2059 | 0.010 |
Why?
|
Adolescent | 1 | 2017 | 85405 | 0.010 |
Why?
|
Aged | 1 | 2021 | 162698 | 0.010 |
Why?
|
Middle Aged | 1 | 2021 | 212863 | 0.000 |
Why?
|